Cape Bio Pharms (Pty) Ltd

Cape Bio Pharms was started up to produce proteins in transiently modified tobacco plants at commercial scale.  The proteins can be used as reagents, incorporated in diagnostics and even as vaccines.  UCT has drawn together a partnership with a company that will undertake the purification and marketing of the proteins into their current market base. The products have been selected based on a NIPMO-funded strategic review and TIA Seed Funding support to the Biopharming Research Unit (Molecular & Cell Biology) was used to further developed of the products. These will create a pipeline of products that will be commercialised by the company.